Table 3

Association of dog ownership with initiation of medication for hypertension drugs, dyslipidaemia and diabetes by breed group in the National cohort with non-dog owners as the reference group

Breed GroupsAntihypertensive drugsLipid-lowering drugsGlucose -lowering drugs
Crude* HRAdjusted HRCrude* HRAdjusted† HRCrude* HRAdjusted† HR
Sheep and cattle dogs1.04 (1.01–1.07)1.03 (1.00–1.06)1.01 (0.97–1.06)1.01 (0.97–1.06)1.03 (0.95–1.13)1.06 (0.96–1.15)
Pinscher and schnauzer1.03 (0.99–1.06)1.03 (1.00–1.07)1.07 (1.02–1.12) 1.07 (1.02–1.12) 0.92 (0.82–1.02)0.98 (0.88–1.09)
Terriers0.98 (0.95–1.02)0.99 (0.96–1.03)1.01 (0.96–1.05)1.02 (0.97–1.07) 0.84 (0.76–0.94) 0.91 (0.81–1.01)
Dachshunds1.01 (0.96–1.06)1.02 (0.97–1.07)1.06 (0.99–1.13)1.06 (0.99–1.13)0.96 (0.84–1.11)1.03 (0.89–1.18)
Spitz and primitive types1.05 (1.01–1.09)1.00 (0.97–1.04)1.04 (0.99–1.09)1.01 (0.96–1.06) 0.82 (0.73–0.91) 0.83 (0.74–0.93)
Scent hounds and related1.05 (1.00–1.09)1.03 (0.98–1.07)1.07 (1.01–1.13)1.05 (0.99–1.11) 0.86 (0.76–0.98) 0.88 (0.77–0.99)
Pointing dogs0.95 (0.89–1.02)0.95 (0.88–1.02)0.96 (0.88–1.06)0.97 (0.89–1.07) 0.65 (0.51–0.82) 0.73 (0.58–0.93)
Retrievers1.00 (0.98–1.03)1.02 (0.99–1.05)1.00 (0.96–1.04)1.02 (0.98–1.06) 0.87 (0.80–0.95) 0.98 (0.90–1.06)
Companion and toy dogs 1.10 (1.06–1.13) 1.09 (1.05–1.12) 1.12 (1.08–1.17) 1.12 (1.07–1.16) 1.01 (0.92–1.12)1.03 (0.93–1.14)
Sight hounds0.90 (0.79–1.02)0.90 (0.79–1.02)0.94 (0.79–1.12)0.94 (0.79–1.12)0.84 (0.57–1.26)0.87 (0.59–1.30)
Mixed pedigree 1.10 (1.07–1.13) 1.07 (1.05–1.11) 1.09 (1.06–1.12) 1.09 (1.05–1.13) 1.22 (1.13–1.32) 1.18 (1.09–1.27)
  • Estimates that pass Bonferroni correction for 11 breed groups (p=0.05/11) are marked in bold.

  • *Adjusted for age and sex.

  • †Adjusted for age, sex, marital status, presence of children in the home, population density, area of residence, education level, region of birth, income and a correction for latitude of residence.

  • ‡Group comprising all non-pure pedigree dogs.